Which statement describes curative options for early-stage hepatocellular carcinoma (Stage 0/A)?

Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

In early-stage hepatocellular carcinoma, the aim is curative, so the treatments that can truly eradicate the cancer are surgical resection, liver transplantation, and local ablation.

Resection removes the tumor from the liver and is most successful when liver function is preserved and there is enough healthy liver left after removing the tumor. It’s a good option for a patient with a limited tumor burden and favorable liver reserve.

Liver transplantation goes further by replacing the diseased liver (often cirrhotic) along with removing the tumor. This approach is curative because it addresses both the cancer and the underlying liver disease, but it requires careful patient selection and access to a donor organ.

Ablation destroys tumor tissue in place, typically with energy sources like radiofrequency or microwave. It can be curative for small tumors and is especially useful when surgery isn’t feasible or the patient is a poor surgical candidate. The destruction is aimed to include a margin of surrounding tissue to reduce recurrence.

Transarterial chemoembolization and systemic therapy are generally used for noncurative goals in earlier stages (as bridge or downstaging strategies or for those who aren’t surgical candidates) and thus do not provide a cure on their own. Palliative care or observation alone does not eradicate the tumor.

So, the best curative options for early-stage disease are resection, transplantation, and ablation.